Lars Fruergaard Jørgensen

Lars Fruergaard Jørgensen is a prominent Danish business executive who serves as the President and CEO of Novo Nordisk, a global healthcare company specializing in diabetes care and other chronic diseases, and Chairman of the European Federation of Pharmaceutical Industries and Associations. Jørgensen has built a distinguished career within Novo Nordisk, demonstrating exceptional leadership and strategic vision.

Jørgensen's career at Novo Nordisk began in 1991, and he has held various key positions within the company, contributing significantly to its growth and global presence. Before becoming CEO in 2017, Jørgensen served as Executive Vice President and Chief Information Officer, where he played a crucial role in enhancing the company's IT and digital infrastructure.

Under Jørgensen's leadership, the company has continued to innovate and expand its portfolio, particularly in the fields of diabetes care, obesity, and other serious chronic diseases. He has been instrumental in driving Novo Nordisk’s commitment to sustainability and social responsibility, ensuring the company not only advances medical treatments but also addresses broader health and environmental challenges.

Jørgensen is known for his strategic acumen, focus on innovation, and dedication to improving patient outcomes. His leadership style emphasizes collaboration, transparency, and a strong commitment to Novo Nordisk’s values. He was named as the Financial Times Person of the Year in December 2023.

Jørgensen holds a Master of Science in Finance and Business Administration from Aarhus School of Business, Aarhus University in Denmark.